Getting COVID-19 when you’re vaccinated isn’t the same as getting COVID-19 when you’re unvaccinated.
Our writers tackle the mysteries of reinfection and the antiviral Paxlovid. Then: Why didn’t the police act faster in the school shooting in Uvalde?
Will the danger mount each time, or will it fade away?
Why violence demands not just policy solutions, but public-health ones
Our original-recipe shots are holding up against new variants. But we may need to improve them, and soon.
Could humans be to blame?
Experts are expected to choose a vaccine recipe for the fall, when Omicron may or may not still be the globe’s dominant variant.
Early anecdotes about Paxlovid’s effects on long COVID are intriguing, but no one’s testing them in clinical trials yet.
Compared with what the U.S. saw in January, the current rise in cases so far looks pretty chill. Is it, though?
With time and effort, we can build enough protection to blunt surges—but herd immunity remains out of reach.
Breed doesn’t have that big an effect on a dog’s personality.
A lot has changed since last year’s pre-Delta lull, but America can still reclaim some coronavirus-free chill—if it decides to commit.
Months of confusing messaging, piled onto existing inequities, kneecapped America’s booster campaign before it had really started.
The elite rule with an iron fist—and a giant spleen.
The United States could be in for a double whammy: a surge it cares to neither measure nor respond to.
A rare animal found a rare plant. Then, it seems, the two teamed up.
Boosters are officially back, and kids under 5 may soon get their first vaccinations. We do the math on the “magic number.” Plus: Maybe don’t make happiness your main goal.
After a stellar run in adult and teen trials, the vaccines are now trying to contend with Omicron, and the numbers show it.
Boa constrictors have figured out a way to inflate only parts of their lungs.
Whenever it arrives, the next surge could put the country’s tolerance for disease and death in full relief.
The successes and failures of annual flu-shot campaigns hold lessons for the future of COVID vaccines.